Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Pharmacokinetics|December 25, 2004
Metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenyl-ethoxy)-phenyl]-ethyl-amine-monohydrochloride (NE-100), a novel sigma ligand: contribution of cytochrome P450 forms involved in the formation of individual metabolites in human liver and small intestineTakahito Yamamoto, Naoko Hagima, Misako Fukasawa, et al.
Heart and Vessels|April 9, 2013
Takotsubo cardiomyopathy in siblingsMasayasu Ikutomi, Masao Yamasaki, Masashiro Matsusita, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 23, 2015
Preclinical metabolism and disposition of luseogliflozin, a novel antihyperglycemic agentMasatoshi Hasegawa, Yukihiro Chino, Nobuko Horiuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 22, 2016
Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion StudiesKoji Kato, Yoshitaka Hasegawa, Katsuya Iwata, et al.
The International Journal of Neuropsychopharmacology|June 13, 2018
No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation ModelLijia Chang, Hidetoh Toki, Youge Qu, et al.
Pharmacology Research & Perspectives|March 16, 2024
Preclinical metabolism and the disposition of vornorexant/TS-142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomniaYoshihiro Konno, Shunsuke Kamigaso, Hidetoh Toki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 27, 2018
(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in miceJun-Ichi Yamaguchi, Hidetoh Toki, Youge Qu, et al.
International Journal of Cardiology|May 10, 2012
Chronic kidney disease and long-term outcomes of myocardial infarctionMichitaka Nagashima, Nobuhisa Hagiwara, Ryo Koyanagi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 22, 2016
In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitorYukihiro Chino, Masatoshi Hasegawa, Yoshiki Fukasawa, et al.
Cardiovascular Diabetology|January 6, 2010
Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularizationAyako Takara, Hiroshi Ogawa, Yasuhiro Endoh, et al.
Pageof 5